Published in
Wiley, Asia-Pacific Journal of Clinical Oncology, 2(14), p. e45-e49, 2017
DOI: 10.1111/ajco.12686
Links
Tools
Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia
Journal article published in 2017 by
Megan Crumbaker 
,
Alexander Guminski,
Howard Gurney,
Dhanusha Sabanathan,
Shirley Wong,
Nick Pavlakis
,
Alexander Guminski,
Howard Gurney,
Dhanusha Sabanathan,
Shirley Wong,
Nick Pavlakis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 